umifenovir has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haid, S; Pécheur, EI; Pietschmann, T | 1 |
| Boriskin, YS; Pécheur, EI; Polyak, SJ | 1 |
2 other study(ies) available for umifenovir and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.
Topics: Carcinoma, Hepatocellular; Cholesterol; Electroporation; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Hydrogen-Ion Concentration; Immunoenzyme Techniques; Immunoprecipitation; Indoles; Liposomes; Liver Neoplasms; Luciferases; RNA, Viral; Sphingomyelins; Transcription, Genetic; Tumor Cells, Cultured; Viral Envelope Proteins; Virion; Virus Internalization | 2009 |
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.
Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Indoles; Interferon-beta; Membrane Fusion; Microbial Viability; Receptors, Retinoic Acid; RNA, Viral; Signal Transduction; Virus Replication | 2006 |